ARCHIVES

Clinical Trials: For ER+ Breast Cancer, Post-Tamoxifen, NSABP Testing Aromasin In Large Trial

This article is from The Cancer Letter archive.

Vol. 27 No. 22 | June 1, 2001

Download PDF Visit The Full Archive

Related Articles

Avon Awards $30M To 13 Organizations

September 27, 2002

Skipper’s Impact: Drugs Curing 40,000 a Year

March 27, 1981

ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic.

April 9, 2010

Breast Cancer Awareness High, Knowledge Of Facts Low,

October 5, 2007

Letters: Broder Response To Waxman Called Political Back-Pedaling

February 11, 1994

Funding opportunities listed.

March 12, 2004